Feedback / Questions
lirentelimab (AK002) - Allakos
lirentelimab subcutaneous (AK002 SC) - Allakos
Eucrisa (crisaborole) - Pfizer
https://djbpnesxepydt.cloudfront.net/radv/April2023/April-2023-Abstracts/365_Abstract_Ph-2-Trial-in-Progress_Lirentelimab_Rodriguez-et-al_1682462083152.pdf
Cristian Rodriguez MD1; Anesa Moyer1; Alan T. Chang1; Enoch Bortey PhD1; and Craig Paterson MD1
Jun 19, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next